Document is current
Any future updates will be listed below
-
Authors
Dhana, Klodian https://orcid.org/0000-0002-6397-7009
Aggarwal, Neelum T.
Voigt, Robin M.
Ventrelle, Jennifer
Rajan, Kumar B.
Kaddurah-Daouk, Rima
Marcovina, Santica M.
Liu, Xiaoran
Agarwal, Puja https://orcid.org/0000-0002-0274-6653
Tangney, Christy
Arfanakis, Konstantinos
Sacks, Frank M.
Barnes, Lisa L.
- License Information
-
More Information
Article History
Received: 13 March 2025
Revised: 25 July 2025
Accepted: 27 August 2025
First Online: 3 October 2025
Competing interests
: Dr. Kaddurah-Daouk in an inventor on a series of patents on use of metabolomics for the diagnosis and treatment of CNS diseases and holds equity in Metabolon Inc., Chymia LLC and PsyProtix.
: The MIND trial followed the ethical standards of the 1964 Declaration of Helsinki and its later amendments and was approved by the institutional review boards at Rush University Medical Center, Harvard School of Public Health, and Brigham and Women’s Hospital. All the participants provided written informed consent.
